Background technology of novel coronavirus (COVID-19) antigen detection kits
An expert in novel coronavirus (COVID-19) antigen detection reagents - Baili Medical Supplies (Xiamen) Co.,Ltd. today introduces you to the background technology of novel coronavirus (COVID-19) antigen detection kits.
Our COVID-19 Antigen Rapid Test Card (Colloidal Gold) series of products have become a hot-selling product in the market, and buyers from all over the world are welcome to wholesale and buy!
Background technique:
The 2019 novel coronavirus (covid-19), which was discovered due to cases of viral pneumonia in 2019, was named by the World Health Organization on January 12, 2020. and Middle East respiratory syndrome virus (mers) and severe acute respiratory syndrome virus (sars) belong to betacoronaviruses, which are zoonotic pathogens, which can cause infection between animals and humans, and can also cause infection between humans and humans. Infect. COVID-19 contains hallmark proteins such as spike (s) protein, membrane (m) protein, and nucleocapsid (n) protein. In order to obtain effective treatment, rapid diagnosis of covid-19 is very important. Rapid identification can reduce hospitalization time, reduce the use of antiviral drugs and reduce hospitalization costs, which greatly saves resources. The covid-19 antigen rapid detection kit (colloidal gold immunochromatography) provides a simple and rapid detection of the new coronavirus in oral and throat swabs and nasal swab samples, which is helpful for early treatment due to its simplicity and rapidity Improve efficiency.
At present, the detection method for the new coronavirus (covid-19) is mainly PCR nucleic acid detection, but this detection method has high technical requirements and is prone to false negatives. It takes a long time to detect the new coronavirus, and requires professional and technical personnel to operate and judge the test results. It cannot be applied to the early preliminary screening of the community, grass-roots hospitals, airports, customs and even families.
Therefore, there is an urgent need for a more convenient, more accurate, faster and more effective diagnostic reagent for the detection of novel coronavirus (covid-19) for early differential diagnosis.